Bulletin 135 Antipsychotics update

Source:
PrescQIPP
Publisher:
PrescQIPP
Publication date:
10 August 2016

Abstract

This Antipsychotics bulletin includes cost effective choices of modified release quetiapine products (for those organisations wishing to use branded generic prescribing). There are two briefings and datapacks to support this bulletin. One is for switching from quetiapine XL to quetiapine immediate release (IR) or cost effective branded products where applicable, and the other a general one which focuses on making local prescribing choices and also includes advice on switching from olanzapine lyophilisates tablets to orodispersible tablets and risperidone orodispersible to standard risperidone tablets as appropriate.